InDex Pharmaceuticals is funded by high-quality venture investors including Industrifonden and SEB Venture Capital.
Industrifonden invests in small and medium-sized Swedish companies with international growth potential. Value is created by working closely and actively with the companies. All investments are based on commercial terms with entrepreneurs and other investors.
SEB Venture Capital
SEB is one of the most highly regarded companies in the Nordic venture capital sector. SEB invests in unlisted companies with growth potential and healthy chances of international expansion. These operations also need to have a long-term, sustainable competitive edge and be managed by people with the requisite entrepreneurial drive and experience.